Solventum Corporation (SOLV) Reports Q2 2025 Results; Mizuho and Wells Fargo Reiterate Their Ratings
On August 7, 2025, Solventum Corporation (NYSE:SOLV) announced its results for Q2 2025.
Solventum Corp (SOLV)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Trian Partners Nelson Peltz | 8,462,819 | $641,820,193 | 16.93% | |
| 2. | Madison Avenue Partners Eli Samaha | 2,244,344 | $170,211,049 | -21% | 11.36% |
| 3. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,319,800 | $100,093,632 | -10% | 0.07% |
| 4. | Candlestick Capital Management Jack Woodruff | 947,174 | $71,833,676 | -21% | 1.37% |
| 5. | AQR Capital Management Cliff Asness | 780,565 | $58,838,993 | -32% | 0.05% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 16,253,361 | $1,232,654,899 | 0.02% | |
| 2. | 10,141,066 | $769,098,445 | 5.12% | |
| 3. | 9,646,550 | $731,594,277 | 0.01% | |
| 4. | 6,108,010 | $463,231,478 | 0.02% | |
| 5. | 5,492,661 | $416,563,410 | 2.23% |
News See All
12 Cheap Value Stocks to Buy Now According to Seth Klarman
Seth Klarman, one of the most esteemed figures in value investing, has achieved success through his steadfast commitment to holding investments for the long term, allowing intrinsic value to be fully ...
Solventum Corporation (NYSE:SOLV) Q2 2025 Earnings Call Transcript
Operator: Good afternoon. My name is Kate, and I will be your conference call operator today. I would like to welcome everyone to Solventum's Second Quarter 2025 Earnings Call.
Morgan Stanley Upgrades Solventum (SOLV) on Growth Potential
Solventum Corporation (NYSE:SOLV) ranks among the best medical stocks to buy according to analysts.
11 Best Medical Stocks to Buy According to Analysts
As macroeconomic headwinds, regulatory reforms, and geopolitical concerns converge in the second half of 2025, PwC predicts that the health industry's resilience and adaptability will be put to the test...
Solventum Corp (SOLV) Upgraded to a ‘Buy’ at Argus Research
Solventum Corporation (NYSE:SOLV) is one of the 15 successful spin-off companies.
15 Successful Spin-Off Companies and Their 2025 Returns
Don’t chase the markets; instead, wait for things to cool off. That’s the sentiment echoed across Wall Street, with markets at record highs.
Solventum Amends Thermo Fisher Deal, Retains Water Filtration Business
Solventum Corporation (NYSE:SOLV) is one of the best new stocks to buy now. On June 25, Solventum announced an amendment to its transaction agreement with Thermo Fisher Scientific Inc. (NYSE:TMO).
13 Best New Stocks to Buy Now
On June 21, Ashley MacNeill, Vista Equity Partners' head of equity capital markets, joined CNBC's 'Closing Bell' to discuss outlooks on the IPO market.
Solventum Corporation (NYSE:SOLV) Q1 2025 Earnings Call Transcript
Operator: Good afternoon. My name is Amy [ph] and I will be your conference call operator for today. I would like to welcome everyone to the Solventum First Quarter 2025 Earnings Call.
Billionaire Hedge Funds
